CPC G16H 50/20 (2018.01) [G16B 5/00 (2019.02); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 50/70 (2018.01); G16H 70/60 (2018.01)] | 20 Claims |
1. A method to perform a treatment on an individual, comprising:
obtaining a panel of analyte measurements, wherein the analytes have been extracted from an individual;
entering the measurements of analytes as features in a computational predictive model to predict a steady-state plasma glucose level of the individual, wherein the computational predictive model has been trained utilizing data derived from a collection of individuals that have had their steady-state plasma glucose level clinically evaluated and their analytes extracted and measured;
receiving a diagnosis from the computational model that the individual has an elevated steady-state plasma glucose level; and
based on the received diagnosis that the individual has an elevated steady-state glucose level, treating the individual to lower the individual's elevated steady-state plasma glucose.
|